Lotfi S. Identification of Deferasirox as a Potential Carbonic Anhydrase II Inhibitor for Glaucoma treatment via Virtual Screening. J Ophthalmol Opto Sci . [Internet]. 2022 Jan. 1 [cited 2026 Jul. 25];6(1):28-41. Available from: https://journals.sbmu.ac.ir/basir/article/view/42856